Literature DB >> 350483

A controlled study of tryptophan-benserazide in schizophrenia.

Q Chouinard, L Annable, S N Young, T L Sourkes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 350483

Source DB:  PubMed          Journal:  Commun Psychopharmacol        ISSN： 0145-5699


× No keyword cloud information.
  6 in total

1.  Increased central 5-hydroxytryptamine receptor mechanisms in rats after chronic neuroleptic treatment.

Authors:  D Dawbarn; S K Long; C J Pycock
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

Review 2.  The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.

Authors:  D C Ohuoha; T M Hyde; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels.

Authors:  S N Young; S Gauthier; G Chouinard; G M Anderson; W C Purdy
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

4.  Tryptophan in alcoholism treatment II: inhibition of the rat liver mitochondrial low Km aldehyde dehydrogenase activity, elevation of blood acetaldehyde concentration and induction of aversion to alcohol by combined administration of tryptophan and benserazide.

Authors:  Abdulla A-B Badawy; Samina Bano; Alex Steptoe
Journal:  Alcohol Alcohol       Date:  2011-09-06       Impact factor: 2.826

Review 5.  Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.

Authors:  Abdulla A-B Badawy
Journal:  Int J Tryptophan Res       Date:  2017-03-15

6.  Tryptophan Metabolism in Rat Liver After Administration of Tryptophan, Kynurenine Metabolites, and Kynureninase Inhibitors.

Authors:  Abdulla A-B Badawy; Samina Bano
Journal:  Int J Tryptophan Res       Date:  2016-08-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.